Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis

The Lancet Infectious Diseases

Volumn 14, Issue 8, 2014, Pages 763-772

  Liu, Quan ^a,b   He, Biao ^b   Huang, Si Yang ^a   Wei, Feng ^c   Zhu, Xing Quan ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; FEVER; HUMAN; NONHUMAN; PATHOGENESIS; PHLEBOVIRUS; PHLEBOVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS; THROMBOCYTOPENIA; TICK BORNE DISEASE; VIRUS GENOME; VIRUS TRANSMISSION;

ANIMALS; ARTHROPOD VECTORS; BUNYAVIRIDAE INFECTIONS; CHINA; COMMUNICABLE DISEASES, EMERGING; DISEASE RESERVOIRS; HUMANS; JAPAN; KOREA; MORTALITY; PHLEBOVIRUS; TICK-BORNE DISEASES; TICKS; ZOONOSES;

EID: 84904720901     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70718-2     Document Type: Review

References (135)

1. Xu B, Liu L, Huang X, et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog 2011, 7:e1002369.
2. Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011, 364:1523-1532.
3. Xu B, Chen H, Zhu Q, Zhang J, Xia S The epidemiological investigation on the first outbreak of Tsutsugamushi disease in Henan Province. Henan J Prev Med 2006, 17:3. (in Chinese).
4. Zhang L, Liu Y, Ni D, et al. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 2008, 300:2263-2270.
5. Jin H, Wei F, Liu Q, Qian J Epidemiology and control of human granulocytic anaplasmosis: a systematic review. Vector Borne Zoonotic Dis 2012, 12:269-274.
6. Guide for severe fever with thrombocytopenia syndrome control (2010 edit) National Health and Family Planning Commission of the People's Replublic China, (in Chinese; accessed Sept 23, 2013). http://www.moh.gov.cn/mohwsyjbgs/s8348/201010/49272.shtml.
7. Zhang YZ, Zhou DJ, Qin XC, et al. The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol 2012, 86:2864-2868.
8. Takahashi T, Maeda K, Suzuki T, et al. The first identification and retrospective study of severe Fever with thrombocytopenia syndrome in Japan. J Infect Dis 2014, 209:816-827.
9. Kim KH, Yi J, Kim G, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis 2013, 19:1892-1894.
10. Denic S, Janbeih J, Nair S, Conca W, Tariq WU, Al-Salam S Acute thrombocytopenia, leucopenia, and multiorgan dysfunction: the first case of SFTS Bunyavirus outside China?. Case Rep Infect Dis 2011, 2011:204056.
11. McMullan LK, Folk SM, Kelly AJ, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med 2012, 367:834-841.
12. Lam TT, Liu W, Bowden TA, et al. Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus. Epidemics 2013, 5:1-10.
13. Bowden TA, Bitto D, McLees A, Yeromonahos C, Elliott RM, Huiskonen JT Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike. PLoS Pathog 2013, 9:e1003374.
14. Doceul V, Lara E, Sailleau C, et al. Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe. Vet Res 2013, 44:31.
15. Bastos MS, Figueiredo LT, Naveca FG, et al. Identification of Oropouche Orthobunyavirus in the cerebrospinal fluid of three patients in the Amazonas, Brazil. Am J Trop Med Hyg 2012, 86:732-735.
16. Lambert AJ, Blair CD, D'Anton M, et al. La Crosse virus in Aedes albopictus mosquitoes, Texas, USA, 2009. Emerg Infect Dis 2010, 16:856-858.
17. Chen S Molecular evolution of Crimean-Congo hemorrhagic fever virus based on complete genomes. J Gen Virol 2013, 94:843-850.
18. Yadav PD, Vincent MJ, Khristova M, et al. Genomic analysis reveals Nairobi sheep disease virus to be highly diverse and present in both Africa, and in India in the form of the Ganjam virus variant. Infect Genet Evol 2011, 11:1111-1120.
19. Lian S, Lee JS, Cho WK, et al. Phylogenetic and recombination analysis of tomato spotted wilt virus. PLoS ONE 2013, 8:e63380.
20. Ikegami T Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res 2012, 95:293-310.
21. Palacios G, Tesh R, Travassos da Rosa A, et al. Characterization of the Candiru antigenic complex (Bunyaviridae: Phlebovirus), a highly diverse and reassorting group of viruses affecting humans in tropical America. J Virol 2011, 85:3811-3820.
22. Zhioua E, Moureau G, Chelbi I, et al. Punique virus, a novel phlebovirus, related to sandfly fever Naples virus, isolated from sandflies collected in Tunisia. J Gen Virol 2010, 91:1275-1283.
23. Carhan A, Uyar Y, Ozkaya E, et al. Characterization of a sandfly fever Sicilian virus isolated during a sandfly fever epidemic in Turkey. J Clin Virol 2010, 48:264-269.
24. Bichaud L, Dachraoui K, Piorkowski G, et al. Toscana virus isolated from sandflies, Tunisia. Emerg Infect Dis 2013, 19:322-324.
25. Li JL, Ling JX, Liu DY, et al. Genetic characterization of a new subtype of Hantaan virus isolated from a hemorrhagic fever with renal syndrome (HFRS) epidemic area in Hubei Province, China. Arch Virol 2012, 157:1981-1987.
26. Plyusnin A, Beaty BJ, Elliott RM, et al. Family Bunyaviridae. Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses 2011, 725-741. Elsevier, London. 1st edn. A.M.Q. King, M.J. Adams, E.B. Carstens, E.J. Lefkowitz (Eds.).
27. Walter CT, Barr JN Recent advances in the molecular and cellular biology of bunyaviruses. J Gen Virol 2011, 92:2467-2484.
28. Appannanavar SB, Mishra B An update on crimean congo hemorrhagic Fever. J Glob Infect Dis 2011, 3:285-292.
29. LaBeaud AD, Kazura JW, King CH Advances in Rift Valley fever research: insights for disease prevention. Curr Opin Infect Dis 2010, 23:403-408.
30. Klein SL, Calisher CH Emergence and persistence of hantaviruses. Curr Top Microbiol Immunol 2007, 315:217-252.
31. Bishop DH, Calisher CH, Casals J, et al. Bunyaviridae. Intervirology 1980, 14:125-143.
32. Palacios G, Savji N, Travassos da Rosa A, et al. Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct species. J Virol 2013, 87:3187-3195.
33. Dilcher M, Alves MJ, Finkeisen D, Hufert F, Weidmann M Genetic characterization of Bhanja virus and Palma virus, two tick-borne phleboviruses. Virus Genes 2012, 45:311-315.
34. Matsuno K, Weisend C, Travassos da Rosa AP, et al. Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses. J Virol 2013, 87:3719-3728.
35. Sun Y, Guo Y, Lou Z A versatile building block: the structures and functions of negative-sense single-stranded RNA virus nucleocapsid proteins. Protein Cell 2012, 3:893-902.
36. Qi X, Lan S, Wang W, et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 2010, 468:779-783.
37. Guo Y, Wang W, Ji W, et al. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc Natl Acad Sci USA 2012, 109:5046-5051.
38. Zhou H, Sun Y, Wang Y, et al. The nucleoprotein of severe fever with thrombocytopenia syndrome virus processes a stable hexameric ring to facilitate RNA encapsidation. Protein Cell 2013, 4:445-455.
39. Walter CT, Bento DF, Alonso AG, Barr JN Amino acid changes within the Bunyamwera virus nucleocapsid protein differentially affect the mRNA transcription and RNA replication activities of assembled ribonucleoprotein templates. J Gen Virol 2011, 92:80-84.
40. Ferron F, Li Z, Danek EI, et al. The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes. PLoS Pathog 2011, 7:e1002030.
41. Blakqori G, Delhaye S, Habjan M, et al. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 2007, 81:4991-4999.
42. Bouloy M, Janzen C, Vialat P, et al. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 2001, 75:1371-1377.
43. Weber F, Bridgen A, Fazakerley JK, et al. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 2002, 76:7949-7955.
44. Qu B, Qi X, Wu X, et al. Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol 2012, 86:8388-8401.
45. Sun Y, Qi Y, Liu C, et al. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. J Virol 2014, 88:237-248.
46. Reguera J, Weber F, Cusack S Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog 2010, 6:e1001101.
47. Bourhy H, Kissi B, Audry L, et al. Ecology and evolution of rabies virus in Europe. J Gen Virol 1999, 80:2545-2557.
48. Zou Y, Hu J, Wang ZX, et al. Molecular diversity and phylogeny of Hantaan virus in Guizhou, China: evidence for Guizhou as a radiation center of the present Hantaan virus. J Gen Virol 2008, 89:1987-1997.
49. Wu A, Su C, Wang D, et al. Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe 2013, 14:446-452.
50. Sall AA, Zanotto PM, Sene OK, et al. Genetic reassortment of Rift Valley fever virus in nature. J Virol 1999, 73:8196-8200.
51. Ding NZ, Luo ZF, Niu DD, et al. Identification of two severe fever with thrombocytopenia syndrome virus strains originating from reassortment. Virus Res 2013, 178:543-546.
52. He CQ, Ding NZ Discovery of severe fever with thrombocytopenia syndrome bunyavirus strains originating from intragenic recombination. J Virol 2012, 86:12426-12430.
53. He CQ, Ding NZ, Mou X, et al. Identification of three H1N1 influenza virus groups with natural recombinant genes circulating from 1918 to 2009. Virology 2012, 427:60-66.
54. He CQ, Xie ZX, Han GZ, et al. Homologous recombination as an evolutionary force in the avian influenza A virus. Mol Biol Evol 2009, 26:177-187.
55. He CQ, Han GZ, Wang D, et al. Homologous recombination evidence in human and swine influenza A viruses. Virology 2008, 380:12-20.
56. Wittmann TJ, Biek R, Hassanin A, et al. Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. Proc Natl Acad Sci USA 2007, 104:17123-17127.
57. Plyusnin A, Kukkonen SK, Plyusnina A, Vapalahti O, Vaheri A Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment. EMBO J 2002, 21:1497-1503.
58. Sibold C, Meisel H, Krüger DH, et al. Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol 1999, 73:667-675.
59. Liu Y, Li Q, Hu W, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis 2012, 12:156-160.
60. Cui F, Cao HX, Wang L, et al. Clinical and epidemiological study on severe fever with thrombocytopenia syndrome in Yiyuan County, Shandong Province, China. Am J Trop Med Hyg 2013, 88:510-512.
61. Zhao L, Zhai S, Wen H, et al. Severe fever with thrombocytopenia syndrome virus, Shandong Province, China. Emerg Infect Dis 2012, 18:963-965.
62. Jiao Y, Zeng X, Guo X, et al. Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay. J Clin Microbiol 2012, 50:372-377.
63. Zhang X, Liu Y, Zhao L, et al. An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV. Sci China Life Sci 2013, 56:697-700.
64. Zhan JB, Huo XX, Guan XH, et al. Analysis on antibody levels against severe fever with thrombocytopenia syndrome bunyavirus among healthy population in Hubei province. Chin J Health Lab Techn 2013, 23:992-993. (in Chinese).
65. Four die from tickborne severe fever with thrombocytopenia syndrome (SFTS) South Korea, (accessed Sept 20, 2013). http://blogs.uw.edu/apecein/2013/06/07/south-korea-four-die-from-tickborne-severe-fever-with-thrombocytopenia-syndrome-sfts/.
66. Severe fever with thrombocytopenia syndrome-Japan (05): update ProMEDmail, (accessed Sep 20, 2013). http://www.promedmail.org/direct.php?id=20130410.1636456.
67. Tang X, Wu W, Wang H, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis 2013, 207:736-739.
68. Bao CJ, Guo XL, Qi X, et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 2011, 53:1208-1214.
69. Chen H, Hu K, Zou J, Xiao J A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus. Int J Infect Dis 2013, 17:e206-e208.
70. Mishra AC, Mehta M, Mourya DT, Gandhi S Crimean-Congo haemorrhagic fever in India. Lancet 2011, 378:372.
71. Liu Q, Liu J Fever with thrombocytopenia syndrome virus infection in 17 clinical observation cases. Chin J Integr Med 2011, 50:785-786. (in Chinese).
72. Hu JL, Bao CJ, Qi X, et al. Clinical and epidemiological characteristics on 20 cases of SFTSV infection. Chin J Zoonoses 2012, 28:302-305. (in Chinese).
73. Yu B, Zhang Y, Peng JS, et al. Epidemiological study on data involving 61 hospitalized cases with Huaiyangshan hemorrhagic fever in Wuhan, Hubei province. Chin J Epidemiol 2012, 33:124-127. (in Chinese).
74. Zhang YZ, He YW, Dai YA, et al. Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis 2012, 54:527-533.
75. Zhang ZP, Zhou WS, Sun J, Tang Q The clinical characteristics of 12 cases of SFTS. Jiangsu Med J 2012, 38:583-584. (in Chinese).
76. Ding F, Zhang W, Wang L, et al. Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011-2012. Clin Infect Dis 2013, 56:1682-1683.
77. Liang S, Bao C, Zhou M, et al. Seroprevalence and risk factors for severe Fever with thrombocytopenia syndrome virus infection in jiangsu province, china, 2011. Am J Trop Med Hyg 2014, 90:256-259.
78. Zhang YZ, Zhou DJ, Xiong Y, et al. Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi 2011, 32:209-220. (in Chinese).
79. Jin C, Liang M, Ning J, et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci USA 2012, 109:10053-10058.
80. Xiong WY, Feng ZJ, Matsui T, Foxwell AR Risk assessment of human infection with a novel bunyavirus in China. Western Pac Surveill Response J 2012, 3:61-66.
81. Gai ZT, Zhang Y, Liang MF, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis 2012, 206:1095-1102.
82. Savage HM, Godsey MS, Lambert A, et al. First detection of heartland virus (Bunyaviridae: Phlebovirus) from field collected arthropods. Am J Trop Med Hyg 2013, 89:445-452.
83. Ding S, Yin H, Xu X, et al. A cross-sectional survey of severe fever with thrombocytopenia syndrome virus infection of domestic animals in Laizhou City, Shandong Province, China. Jpn J Infect Dis 2014, 67:1-4.
84. Zhang WS, Zeng XY, Zhou MH, et al. Seroepidemiology of severe fever with thrombocytopenia syndrome bunyavirus in Jiangsu province, China. Dis Surveill 2011, 26:676-678. (in Chinese).
85. Liu L, Guan XH, Xing XS, et al. Epidemiologic analysis on severe fever with thrombocytopenia syndrome in Hubei province, 2010. Zhonghua Liu Xing Bing Xue Za Zhi 2012, 33:168-172. (in Chinese).
86. Ge HM, Wang QK, Li ZF, et al. Investigation of severe fever with thrombocytopenia syndrome (SFTS) virus carrying situation in rodents in SFTS epidemic area of Donghai county. Jiangsu J Prev Med 2012, 23:12-14. (in Chinese).
87. Xing Z, Schefers J, Schwabenlander M, et al. Novel bunyavirus in domestic and captive farmed animals, Minnesota, USA. Emerg Infect Dis 2013, 19:1487-1489.
88. Lv MT, Sun Y, Liu P, Luo EJ Advances in severe fever with thrombocytopenia syndrome virus (SFTSV). J Microbiol 2013, 33:86-88. (in Chinese).
89. Shen AH, Bao CJ, Hu JL, Li LX, Yang HT Survey on clinical and epidemiological characteristics of 6 cases with SFTSV infection. J Southeast Univ (Med Sci Edit) 2012, 31:559-563. (in Chinese).
90. Yuan C, Cui N, Wang BJ, Li W, Zhang L Clinical analysis of 253 patients with severe fever with thrombocytopenia syndrome. Chin J Modern Med 2011, 21:3413-3417. (in Chinese).
91. Sheg YB, Xie YC, Feng F The clinical characteristics of seven cases of severe fever with thrombocytopenia syndrome. Chin J Noxocomiol 2012, 22:1817. (in Chinese).
92. Tao WY, Tao X Eight patients with severe fever with thrombocytopenia syndrome infected with a novel bunyavirus. J Jiangsu Univ 2011, 21:91-92.
93. Chao CL, Sun JM, Lin JF, et al. Analysis of clinical and epidemiological characteristics of severe fever with thrombocytopenia syndrome in Zhejiang Province, China. Chin J Prev Med 2012, 13:904-907. (in Chinese).
94. Weng Y, Chen N, Han Y, Xing Y, Li J Clinical and laboratory characteristics of severe fever with thrombocytopenia syndrome in Chinese patients. Braz J Infect Dis 2014, 18:88-91.
95. Cui N, Bao XL, Yang ZD, et al. Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China. J Clin Virol 2014, 59:12-17.
96. Deng B, Zhou B, Zhang S, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS ONE 2013, 8:e80802.
97. QuanTai X, FengZhe C, XiuGuang S, DongGe C A study of cytological changes in the bone marrow of patients with severe fever with thrombocytopenia syndrome. PLoS ONE 2013, 8:e83020.
98. Lu QB, Cui N, Li H, et al. Case fatality and effectiveness of ribavirin in hospitalized patients with severe fever with thrombocytopenia syndrome in China. Clin Infect Dis 2013, 57:1292-1299.
99. Sun L, Hu Y, Niyonsaba A, et al. Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome. Clin Exp Med 2013, published online Sept 26. 10.1007/s10238-013-0259-0.
100. Deng B, Zhang S, Geng Y, et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS ONE 2012, 7:e41365.
101. Maghazachi AA Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 2010, 341:37-58.
102. Billecocq A, Spiegel M, Vialat P, et al. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004, 78:9798-9806.
103. van Knippenberg I, Carlton-Smith C, Elliott RM The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism. J Gen Virol 2010, 91:2002-2006.
104. Marty AM, Jahrling PB, Geisbert TW Viral hemorrhagic fevers. Clin Lab Med 2006, 26:345-386. viii.
105. Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis 2012, 206:1085-1094.
106. Zoja C, Garcia PB, Remuzzi G The role of chemokines in progressive renal disease. Front Biosci (Landmark Ed) 2009, 14:1815-1822.
107. Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996, 78:47-55.
108. Wasmuth HE, Tacke F, Trautwein C Chemokines in liver inflammation and fibrosis. Semin Liver Dis 2010, 30:215-225.
109. Petreaca ML, Yao M, Liu Y, Defea K, Martins-Green M Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability. Mol Biol Cell 2007, 18:5014-5023.
110. Repeke CE, Ferreira SB, Vieira AE, et al. Dose-response met-RANTES treatment of experimental periodontitis: a narrow edge between the disease severity attenuation and infection control. PLoS ONE 2011, 6:e22526.
111. Ellis M, al-Ramadi B, Hedström U, Frampton C, Alizadeh H, Kristensen J Significance of the CC chemokine RANTES in patients with haematological malignancy: results from a prospective observational study. Br J Haematol 2005, 128:482-489.
112. Seynhaeve AL, Vermeulen CE, Eggermont AM, ten Hagen TL Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell Biochem Biophys 2006, 44:157-169.
113. Liu Y, Wu B, Paessler S, Walker DH, Tesh RB, Yu XJ The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J Virol 2014, 88:1781-1786.
114. Goldsmith CS, Ksiazek TG, Rollin PE, et al. Cell culture and electron microscopy for identifying viruses in diseases of unknown cause. Emerg Infect Dis 2013, 19:886-891.
115. Li Z, Cui L, Zhou M, et al. Development and application of a one-step real-time RT-PCR using a minor-groove-binding probe for the detection of a novel bunyavirus in clinical specimens. J Med Virol 2013, 85:370-377.
116. Sun Y, Liang M, Qu J, et al. Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay. J Clin Virol 2012, 53:48-53.
117. Li Z, Qi X, Zhou M, et al. A two-tube multiplex real-time RT-PCR assay for the detection of four hemorrhagic fever viruses: severe fever with thrombocytopenia syndrome virus, Hantaan virus, Seoul virus, and dengue virus. Arch Virol 2013, 158:1857-1863.
118. Xu H, Zhang L, Shen G, et al. Establishment of a novel one-step reverse transcription loop-mediated isothermal amplification assay for rapid identification of RNA from the severe fever with thrombocytopenia syndrome virus. J Virol Methods 2013, 194:21-25.
119. Cui L, Ge Y, Qi X, et al. Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization. J Clin Microbiol 2012, 50:3881-3885.
120. Yang G, Li B, Liu L, Huang W, Zhang W, Liu Y Development and evaluation of a reverse transcription loop-mediated isothermal amplification assay for rapid detection of a new SFTS bunyavirus. Arch Virol 2012, 157:1779-1783.
121. Huang XY, Hu XN, Ma H, et al. Detection of new bunyavirus RNA by reverse transcription-loop-mediated isothermal amplification. J Clin Microbiol 2014, 52:531-535.
122. Huang BQ Nursing Experience of severe fever with thrombocytopenia syndrome. Chin Prac Med 2011, 6:191-192. (in Chinese).
123. Debing Y, Jochmans D, Neyts J Intervention strategies for emerging viruses: use of antivirals. Curr Opin Virol 2013, 3:217-224.
124. Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis 2009, 28:929-933.
125. Xu R, Yang XY, Yang DF, Zou CY, Gong PL, Zeng FD Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers. Antimicrob Agents Chemother 2009, 53:5055-5059.
126. Winston DJ, Ho WG, Lin CH, et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987, 106:12-18.
127. Lang J, Gravenstein S, Briggs D, et al. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Biologicals 1998, 26:7-15.
128. Casadevall A, Dadachova E, Pirofski LA Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2004, 2:695-703.
129. Guo X, Zhang L, Zhang W, et al. Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus. Clin Vaccine Immunol 2013, 20:1426-1432.
130. Oh WS, Heo ST, Kim SH, Choi WJ, Han MG, Kim JY Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome. Int J Infect Dis 2014, 18:84-86.
131. Wan JS Advances in severe fever with thrombocytopenia syndrome. Anhui J Prev Med 2012, 18:281-284. (in Chinese).
132. Song LH, Qi S, Pang W, Wu W, Zhou W, Liu DH Epidemiology and control measures of severe fever with thrombocytopenia syndrome in Dalian, Liaoning Province, China. J Med Pest Control 2012, 28:1235-1237. (in Chinese).
133. Cisak E, Wójcik-Fatla A, Zajac V, Dutkiewicz J Repellents and acaricides as personal protection measures in the prevention of tick-borne diseases. Ann Agric Environ Med 2012, 19:625-630.
134. Vaughn MF, Meshnick SR Pilot study assessing the effectiveness of long-lasting permethrin-impregnated clothing for the prevention of tick bites. Vector Borne Zoonotic Dis 2011, 11:869-875.
135. Dantas-Torres F, Chomel BB, Otranto D Ticks and tick-borne diseases: a One Health perspective. Trends Parasitol 2012, 28:437-446.